Trial intelligence / Profile preview

Remifentanil + propofol vs dexmedetomidine + propofol for monitored anesthesia care during fiberoptic bronchoscopy

KCT0000064Phase 4Completed

Sponsor
Seoul National University Bundang Hospital
Start
Nov 2010
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of remifentanil, dexmedetomidine, propofol in bronchial carcinoma, bronchiectasis, hemoptysis, sponsored by Seoul National University Bundang Hospital. Started Nov 2010; status: completed.

02

Drugs

remifentanildexmedetomidinepropofol
03

Conditions

bronchial carcinomabronchiectasishemoptysis

Beyond the preview

Go deeper on KCT0000064.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000064.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call